SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

Intra-Cellular Therapies Q4 EPS $(0.74) Beats $(0.81) Estimate, Sales $60.613K

Intra-Cellular Therapies (NASDAQ:ITCI) reported quarterly losses of $(0.74) per share which beat the analyst consensus estimate of $(0.81) by 8.64 percent. This is a 1.33 percent increase over losses of $(0.75) per share

Benzinga · 03/02/2020 12:32

Intra-Cellular Therapies (NASDAQ:ITCI) reported quarterly losses of $(0.74) per share which beat the analyst consensus estimate of $(0.81) by 8.64 percent. This is a 1.33 percent increase over losses of $(0.75) per share from the same period last year. The company reported $60.613 thousand in sales this quarter.